Tulaton Sodsri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tulaton Sodsri has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Nattanicha Chaisrimaneepan
Department of Internal Medicine, Texas Tech University Health Sciences Center
2 shared publications - Nutchapon Xanthavanij
Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand
2 shared publications - Pintip Ngamjanyaporn
Division of Allergy, Immunology and Rheumatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
2 shared publications - Tananchai Petnak
Division of Pulmonary and Pulmonary Critical Care Medicine, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
2 shared publications Ben Thiravetyan
1 shared publication- Ben Thiravetyan
Department of Internal Medicine Texas Tech University Health Sciences Center Lubbock Texas USA
1 shared publication
Latest Publications
- Open Access
- 23 October 2025
- Published by Texas Tech University Health Sciences Center Department of Internal Medicine in The Southwest Journal of Medicine
- Vol. 13 (57) , 49-52
Esophageal actinomycosis – a rare cause of odynophagia in an HIV patient
Odynophagia is a common complaint among individuals living with HIV, with candidiasis being the predominant cause. We present a case of 38-year-old man with poorly controlled HIV who presented with odynophagia and oropharyngeal candidiasis that is refractory to antifungal therapy. Further investigations showed esophageal candidiasis with esophageal ulcers, which pathology revealed extensive filamentous bacteria in addition to fungal hyphae. Diagnosis of esophageal candidiasis superimposed with actinomycosis was made, and he responded well to amoxicillin in addition to fluconazole therapy.Keywords: Esophageal actinomycosis, Actinomycosis, Actinomyces, HIV
- 23 October 2025
- Published by Texas Tech University Health Sciences Center Department of Internal Medicine in The Southwest Journal of Medicine
- Vol. 13 (57) , 49-52
Open AccessEsophageal actinomycosis – a rare cause of odynophagia in an HIV patient
Odynophagia is a common complaint among individuals living with HIV, with candidiasis being the predominant cause. We present a case of 38-year-old man with poorly controlled HIV who presented with odynophagia and oropharyngeal candidiasis that is refractory to antifungal therapy. Further investigations showed esophageal candidiasis with esophageal ulcers, which pathology revealed extensive filamentous bacteria in addition to fungal hyphae. Diagnosis of esophageal candidiasis superimposed with actinomycosis was made, and he responded well to amoxicillin in addition to fluconazole therapy.Keywords: Esophageal actinomycosis, Actinomycosis, Actinomyces, HIV
- Open Access
- 1 July 2025
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
- Vol. 33 (3) , 169-188
Non-specific cutaneous lupus erythematosus and clinical significance: a literature review
Nattanicha Chaisrimaneepan, M.D., Thunyaporn Khoruamklang, M.D., Tulaton Sodsri, M.D., Natnicha Jakramonpreeya, M.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.2025.0035
- 1 July 2025
- Published by Korean College of Rheumatology in Journal of Rheumatic Diseases
- Vol. 33 (3) , 169-188
Open AccessNon-specific cutaneous lupus erythematosus and clinical significance: a literature review
Nattanicha Chaisrimaneepan, M.D., Thunyaporn Khoruamklang, M.D., Tulaton Sodsri, M.D., Natnicha Jakramonpreeya, M.D.. J Rheum Dis -0001;0:. https://doi.org/10.4078/jrd.2025.0035
- Open Access
- 28 March 2025
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 34 (1) , 108-114
Constipation and Risk of Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort Studies
Background and Aims: Constipation is commonly seen among patients with cardiovascular diseases and is linked to adverse outcomes. However, the association between constipation and the risk of acute myocardial infarction (AMI) remains conflicting. Therefore, we aimed to conduct a systematic review and meta-analysis to summarize the available data on this topic. Method: We identified potentially eligible studies from the MEDLINE and EMBASE databases, searching from inception to May 2024, to investigate the association between constipation and the risk of developing AMI. To be included, studies needed to compare incidence of AMI between cohorts with and without constipation. Effect size and 95% confidence intervals (CIs) were combined using the generic inverse variance method. All statistical analyses were performed by Review Manager 5.4. Results: Our meta-analysis included seven studies that met the eligibility criteria. There were 5,351,976 participants, with a mean age of 57.8 years and 74% were males. We found that patients with constipation had a 14% increased risk of AMI with a pooled risk ratio (RR) of 1.14 (95%CI: 1.08-1.14; I²=85%; p<0.001) compared to those without constipation. Conclusions: Our study revealed that constipation is associated with a higher risk of AMI. Emphasizing and addressing gastrointestinal health, including constipation, as an important issue is essential for comprehensive cardiovascular care.
- 28 March 2025
- Published by Romanian Society of Gastroenterology and Hepatology in Journal of Gastrointestinal and Liver Diseases
- Vol. 34 (1) , 108-114
Open AccessConstipation and Risk of Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Cohort Studies
Background and Aims: Constipation is commonly seen among patients with cardiovascular diseases and is linked to adverse outcomes. However, the association between constipation and the risk of acute myocardial infarction (AMI) remains conflicting. Therefore, we aimed to conduct a systematic review and meta-analysis to summarize the available data on this topic. Method: We identified potentially eligible studies from the MEDLINE and EMBASE databases, searching from inception to May 2024, to investigate the association between constipation and the risk of developing AMI. To be included, studies needed to compare incidence of AMI between cohorts with and without constipation. Effect size and 95% confidence intervals (CIs) were combined using the generic inverse variance method. All statistical analyses were performed by Review Manager 5.4. Results: Our meta-analysis included seven studies that met the eligibility criteria. There were 5,351,976 participants, with a mean age of 57.8 years and 74% were males. We found that patients with constipation had a 14% increased risk of AMI with a pooled risk ratio (RR) of 1.14 (95%CI: 1.08-1.14; I²=85%; p<0.001) compared to those without constipation. Conclusions: Our study revealed that constipation is associated with a higher risk of AMI. Emphasizing and addressing gastrointestinal health, including constipation, as an important issue is essential for comprehensive cardiovascular care.
- Open Access
- 30 October 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (21) , 6849
Clinical Characteristics of Anti-Synthetase Syndrome and Variables Associated with Interstitial Lung Disease and Mortality: A Retrospective Cohort Study
Anti-synthetase syndrome (ASS) is a rare autoimmune disease. Since the knowledge of ASS remains limited, we conducted the retrospective study aiming to describe clinical characteristics and identify variables associated with interstitial lung disease (ILD) and mortality among patients with ASS. Patients diagnosed with ASS from January 2013 to October 2022 were included. Patient demographics, clinical manifestations, myositis auto-antibody profiles, HRCT findings, and laboratory tests were collected. Variables associated with mortality risk and ILD were evaluated using the Cox proportional hazards model and the logistic regression model, respectively. A total of 82 patients with ASS were included. Clinical manifestations included arthritis (57%), Raynaud’s phenomenon (32%), mechanic’s hands (29%), fever (26%), and myositis (17%). The myositis auto-antibody profiles included anti-PL-7 (29%), anti-Jo-1 (27%), anti-EJ (17%), anti-PL-12 (16%), and anti-OJ (11%). ILD was observed in 64 patients (78%). Among patients with ILD, 21 initially presented with ILD before developing other ASS clinical manifestations, 29 simultaneously presented with ILD and other symptoms, and 14 had isolated ILD throughout follow-up. Overall, 6 patients presented with rapid-progressive ILD. With a median follow-up time of 2.5 years, mortality was observed in 10 patients (12.2%). Factors associated with mortality included increased lymphocyte counts (adjusted HR, 0.74; 95% CI, 0.61–0.91; p < 0.01), isolated ILD (adjusted HR, 9.59; 95% CI, 1.52–60.61; p = 0.02) and the presence of anti-Ro52 antibodies (adjusted HR, 0.14; 95% CI, 0.02–0.93; p = 0.04). Factors associated with ILD included age (adjusted OR, 1.10; 95% CI, 1.03–1.18; p = 0.01), presence of anti-Ro52 antibodies (adjusted OR, 17.92; 95% CI, 2.13–138.68; p = 0.01), and presence of arthritis (adjusted OR, 0.09; 95% CI, 0.01–0.75; p = 0.03). Our study demonstrated a favorable overall mortality rate among ASS patients.
- 30 October 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (21) , 6849
Open AccessClinical Characteristics of Anti-Synthetase Syndrome and Variables Associated with Interstitial Lung Disease and Mortality: A Retrospective Cohort Study
Anti-synthetase syndrome (ASS) is a rare autoimmune disease. Since the knowledge of ASS remains limited, we conducted the retrospective study aiming to describe clinical characteristics and identify variables associated with interstitial lung disease (ILD) and mortality among patients with ASS. Patients diagnosed with ASS from January 2013 to October 2022 were included. Patient demographics, clinical manifestations, myositis auto-antibody profiles, HRCT findings, and laboratory tests were collected. Variables associated with mortality risk and ILD were evaluated using the Cox proportional hazards model and the logistic regression model, respectively. A total of 82 patients with ASS were included. Clinical manifestations included arthritis (57%), Raynaud’s phenomenon (32%), mechanic’s hands (29%), fever (26%), and myositis (17%). The myositis auto-antibody profiles included anti-PL-7 (29%), anti-Jo-1 (27%), anti-EJ (17%), anti-PL-12 (16%), and anti-OJ (11%). ILD was observed in 64 patients (78%). Among patients with ILD, 21 initially presented with ILD before developing other ASS clinical manifestations, 29 simultaneously presented with ILD and other symptoms, and 14 had isolated ILD throughout follow-up. Overall, 6 patients presented with rapid-progressive ILD. With a median follow-up time of 2.5 years, mortality was observed in 10 patients (12.2%). Factors associated with mortality included increased lymphocyte counts (adjusted HR, 0.74; 95% CI, 0.61–0.91; p < 0.01), isolated ILD (adjusted HR, 9.59; 95% CI, 1.52–60.61; p = 0.02) and the presence of anti-Ro52 antibodies (adjusted HR, 0.14; 95% CI, 0.02–0.93; p = 0.04). Factors associated with ILD included age (adjusted OR, 1.10; 95% CI, 1.03–1.18; p = 0.01), presence of anti-Ro52 antibodies (adjusted OR, 17.92; 95% CI, 2.13–138.68; p = 0.01), and presence of arthritis (adjusted OR, 0.09; 95% CI, 0.01–0.75; p = 0.03). Our study demonstrated a favorable overall mortality rate among ASS patients.